DB17696InvestigationalSmall molecule
ASP-8731 is a novel BACH1 inhibitor that potentially induces fetal hemoglobin (HbF). Developed by Mitobridge, it is being investigated for the treatment of sickle cell disease.
- Code names
- ASP-8731
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of ASP-8731, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account